The FDA recently approved a new device from Medtronic that turns a smartphone into a patient’s pacemaker monitor that can send stats to their doctor in real time. The MyCareLink Smart Monitor is able ...
On February 20, 2024, Medtronic MDT Corporation (NYSE: MDT, $85.90, Market Capitalization: $114.2 billion) in its 3Q24 earnings call announced that it no longer plans to spin-off its Patient ...
Medical leaders Medtronic and Abbott are collaborating on diabetes care in a new partnership that will combine technologies to expand options for patients. Medtronic is known for insulin pumps with ...
Abbott Laboratories is linking its continuous glucose monitoring with automated insulin delivery by entering a global partnership with health tech giant Medtronic. The pairing of Abbott's leading ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback